.
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.
."we were quite surprised to find there were no significant differences," says study author
.
financial adviser is the premier weekly newspaper for uk based financial intermediaries.
.